Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001623632-25-000782
Filing Date
2025-07-08
Accepted
2025-07-08 07:50:29
Documents
5

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11021
2 fortebiosciencesexhibit1.htm EX-99 9395
3 fortebiosciencesexhibit2.htm EX-99 14331
4 fortebiosciencesexhibit3trd.htm EX-99 4196
5 fortebiosciencesexhibit3acd.htm EX-99 4156
  Complete submission text file 0001623632-25-000782.txt   45239
Mailing Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222
Business Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222 4122881900
FEDERATED HERMES, INC. (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89959 | Film No.: 251109540
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)